Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Aug
27
2019
NIEHS-Funded Research Finds that Graphene Shield Shows Promise in Blocking Mosquito Bites Bergeson & Campbell, P.C.
Oct
25
2019
EPA Will Publish Draft Risk Evaluation of Methylene Chloride on October 29 Bergeson & Campbell, P.C.
Jun
7
2023
GAO’s Priority Open Recommendations for EPA Include Recommendations Regarding the IRIS Program Bergeson & Campbell, P.C.
Jun
14
2023
Minnesota Will Require Manufacturers to Report Intentionally Added PFAS and Will Ban Intentionally Added PFAS in Certain Product Categories Beginning January 1, 2025 Bergeson & Campbell, P.C.
Jun
16
2023
EPA Proposes to Ban Most Uses of PCE and Establish a WCCP for Uses Not Prohibited Bergeson & Campbell, P.C.
Jun
30
2023
EPA Requests Comments for Implementation of PRIA 5 Bilingual Labeling Requirements for Agricultural Pesticides Bergeson & Campbell, P.C.
Mar
13
2016
OECD Publishes Reports on Physical-Chemical Properties and Categorization of Nanomaterials Bergeson & Campbell, P.C.
Feb
7
2020
EC Requests Scientific Advice from SCCS on the Safety of Nanomaterials in Cosmetics Bergeson & Campbell, P.C.
Feb
24
2020
ECHA Urges Companies to Provide More Data on Nanoforms Bergeson & Campbell, P.C.
Mar
30
2016
NNCO Announces Availability Of QEEN Workshop Report Bergeson & Campbell, P.C.
Feb
28
2020
FDA Upgrades Its Database Of Licensed Biological Products & Amends It's Definition Bergeson & Campbell, P.C.
Aug
1
2023
BETO Will Host Bioenergy Cybersecurity Workshop on September 11, 2023 Bergeson & Campbell, P.C.
Aug
8
2023
EUON Publishes Study Identifying Status of Animal-Free Test Methods for Use on Nanomaterials Bergeson & Campbell, P.C.
May
4
2016
NGOs Call for Actions, Not Words, from the European Commission on Nanotechnology Bergeson & Campbell, P.C.
Oct
10
2023
ACI Recognizes “Early Adopters” of Sustainable Feedstocks Initiative Bergeson & Campbell, P.C.
Jul
1
2016
EFSA Priority Topics for Guidance Development Include Nanotechnologies Bergeson & Campbell, P.C.
Oct
18
2023
OECD Tour de Table Includes Information on U.S. Developments on Human Health and Environmental Safety of Nanomaterials Bergeson & Campbell, P.C.
Oct
24
2023
EPA Announces Winners of the 2023 Green Chemistry Challenge Awards Bergeson & Campbell, P.C.
Apr
23
2020
EPA Remarks That Requirements to Notify EPA of Certain Changes to Disinfectants During COVID-19 May Be Retained Bergeson & Campbell, P.C.
Sep
2
2016
European Commission (EC) Requests Scientific Opinion on Colloidal Silver (Nano) Bergeson & Campbell, P.C.
May
19
2020
EPA Announces Third Temporary Modification to Pesticide Registration Notice 98-10 to Address Supply Chain Issues for Food-Contact Surface Sanitizer Products in Response to COVID-19 Bergeson & Campbell, P.C.
Sep
23
2016
Naval Air Station Successfully Tests Flight With 100 Percent Advanced Biofuel Bergeson & Campbell, P.C.
Jun
5
2020
Workshop On Bioanalysis To Be Held By FDA Bergeson & Campbell, P.C.
Jan
16
2024
Law Library of Congress Publishes Report on Selected Issues in Biotechnology Regulation Bergeson & Campbell, P.C.
Jul
9
2020
ANSI Nanotechnology Standards Panel Will Hold Virtual Workshop on Advanced Materials in August Bergeson & Campbell, P.C.
Feb
21
2024
NNI Webinar on Nanometrology for Nanoscale Medical and Pharmaceutical Products Will Be Held March 1, 2024 Bergeson & Campbell, P.C.
Jan
5
2017
White House Announces Release of Final Update to the Coordinated Framework for the Regulation of Biotechnology Bergeson & Campbell, P.C.
Mar
13
2024
White House OSTP Posts Readout of NNI Symposium Celebrating 20th Anniversary of the 21st Century Nanotechnology R&D Act Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins